Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection

2004 ◽  
Vol 24 (1) ◽  
pp. 65-82 ◽  
Author(s):  
Rodolphe Thiébaut ◽  
Hélène Jacqmin-Gadda ◽  
Abdel Babiker ◽  
Daniel Commenges ◽  
2014 ◽  
Vol 46 ◽  
pp. e48
Author(s):  
M. Basso ◽  
M. Franzetti ◽  
R. Scaggiante ◽  
A. Sattin ◽  
C. Mengoli ◽  
...  

AIDS ◽  
2010 ◽  
Vol 24 (10) ◽  
pp. 1561-1567 ◽  
Author(s):  
Andrew N Phillips ◽  
Fiona C Lampe ◽  
Colette J Smith ◽  
Anna-Maria Geretti ◽  
Alison Rodger ◽  
...  

2014 ◽  
Vol 11 (1) ◽  
pp. 21 ◽  
Author(s):  
Monica Basso ◽  
Marzia Franzetti ◽  
Renzo Scaggiante ◽  
Andrea Sattin ◽  
Carlo Mengoli ◽  
...  

The Lancet ◽  
2004 ◽  
Vol 364 (9443) ◽  
pp. 1428-1434 ◽  
Author(s):  
Jonathan Mermin ◽  
John Lule ◽  
John Paul Ekwaru ◽  
Samuel Malamba ◽  
Robert Downing ◽  
...  

2007 ◽  
Vol 28 (4) ◽  
pp. 173-177 ◽  
Author(s):  
V. Margiotta ◽  
G. Campisi ◽  
S. Mancuso ◽  
V. Accurso ◽  
V. Abbadessa

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 1578-1578
Author(s):  
Eric Oksenhendler ◽  
Laurence Gerard ◽  
Lionel Galicier ◽  
Nicolas Leturque ◽  
Anne Janin ◽  
...  

Abstract Although the incidence of HIV-associated Non-Hodgkin lymphoma (NHL) has decreased since the use of combination antiretroviral therapy (cART) and survival has improved, NHL still represents one of the most frequent and severe complications in HIV-infected patients. Out of the 361 patients included in a cohort of HIV-NHL from 1996 to 2006, 114 patients had undetectable (? 500 copies/ml) plasma HIV-RNA. These patients were included in a study to analyze the characteristics of NHL over time according to the duration of HIV infection control. All available histological samples were reviewed by a single pathologist. Tumor was defined as virus-associated (VposNHL) if EBV (ISH, IHC or PCR) or HHV-8 (IHC or PCR) were detected in the tumor cells, and not virus-associated (VnegNHL) if nor EBV nor HHV8 were detected. Comparisons were performed using non parametric tests. All patients were treated with cART, with a median duration of 24 months (IQR, 2–119). The median duration of HIV replication control was 9.3 months (IQR, 0.13–90.5). Most cases (63%) had occurred within 18 months of HIV control versus only 37% after M18. When comparing characteristics of NHL in patients with less or more than 18 months of HIV control, the patients were older (52 years versus 41 years, P<10–4), have a longer median duration of HIV infection (4 years versus 2.4 years, P=.006), and a higher median CD4 cell count (346 × 106/L versus 275 × 106/L, P=.03) when HIV control was >18 months versus ?18 months. None of the NHL features (histology, phenotype, staging, ECOG, LDH, B symptoms) were different between the 2 groups. Virus-association could be assessed for EBV and HHV-8 in 96 cases (84%): 52 patients presented with a virus-associated tumor (31 EBV+, 13 HHV-8+, 8 both) and 43 tumors were not virus-associated. There was no difference in this repartition according to the duration of HIV control (P=.62). VposNHL VnegNHL VundeterNHL HIV-RNA <500 cop/ml < 18 months 30 28 14 HIV-RNA <500 cop/ml > 18 months 16 13 4 Median CD4 cell count (×106/L) 280 290 317 Virus-associated tumors were neither associated with CD4 cell count (P=.86), nor with CD8 cell count (P=.78). In conclusion, NHL still occur in patients with HIV controled infection (30% of HIV-NHL), but within the first 18 months after plasma HIV-RNA becomes undetectable in most patients. After 18 months, the incidence dramaticaly decreased. However, characteristics of NHL and specifically the association with EBV and/or HHV-8 were not different according to the duration of control of HIV infection.


2005 ◽  
Vol 6 (3) ◽  
pp. 127-135 ◽  
Author(s):  
Rodger D. MacArthur ◽  
George Perez ◽  
Sharon Walmsley ◽  
John D. Baxter ◽  
Christopher M. Mullin ◽  
...  

2003 ◽  
Vol 13 (2) ◽  
pp. 271-282 ◽  
Author(s):  
Rodolphe Thiébaut ◽  
Hélène Jacqmin-Gadda ◽  
Catherine Leport ◽  
Christine Katlama ◽  
Dominique Costagliola ◽  
...  

Author(s):  
Anne M. Rompalo ◽  
Jacquie Astemborski ◽  
Ellie Schoenbaum ◽  
Paula Schuman ◽  
Charles Carpenter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document